|
Real-time Estimate
Cboe Europe
05:55:43 17/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 13,829.00 GBX | -1.46% |
|
-0.37% | +0.30% |
| 01:39pm | Roche Secures First U.S. Approval for New Breast-Cancer Pill | DJ |
| 17/11 | Rhythm drug shows sustained weight reduction in patients with brain damage-related obesity | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.47% | -0.37% | +11.55% | +19.65% | +0.30% | +1.77% | +34.81% | +61.02% | +218.71% | 29TCr | ||
| -0.82% | +1.40% | +13.89% | +21.31% | +33.22% | +39.64% | +143.17% | +455.51% | +1,760.76% | 1,27500Cr | ||
| -1.12% | +0.16% | +10.56% | +8.53% | +36.53% | +44.21% | +88.24% | +73.70% | +142.82% | 68TCr | ||
| -0.16% | +0.43% | +3.20% | +18.08% | +28.91% | +26.76% | +113.01% | +153.01% | +378.63% | 52TCr | ||
| -0.54% | +1.39% | +7.18% | +14.41% | +24.13% | +41.85% | +71.46% | +9.87% | +73.95% | 39TCr | ||
| -2.23% | -2.89% | -1.02% | +6.35% | +37.24% | +55.47% | +41.64% | +71.75% | +130.66% | 36TCr | ||
| -1.31% | -0.31% | +7.94% | +8.64% | +22.32% | +26.73% | +59.41% | +75.89% | +84.40% | 31TCr | ||
| -0.72% | -0.63% | +6.90% | +11.35% | +41.25% | +37.29% | +71.87% | +125.09% | +214.01% | 25TCr | ||
| -0.30% | -1.03% | +7.29% | +21.12% | +36.53% | +34.04% | +124.88% | +150.53% | +120.50% | 21TCr | ||
| -1.76% | +3.28% | +9.32% | -4.10% | -13.79% | -10.33% | -59.61% | -25.58% | +144.04% | 19TCr | ||
| -0.10% | -1.27% | -2.43% | +7.73% | +15.90% | +15.16% | -3.06% | -41.81% | -9.70% | 16TCr | ||
| -0.15% | -2.37% | +7.61% | +6.34% | +18.62% | +23.02% | +56.79% | +185.56% | +494.44% | 14TCr | ||
| -0.79% | +1.27% | +5.32% | -1.41% | +16.67% | +34.90% | +23.78% | +6.48% | +11.98% | 13TCr | ||
| +0.20% | +4.31% | +9.97% | +27.16% | +34.71% | +31.23% | +145.14% | +400.90% | +681.06% | 13TCr | ||
| -1.18% | +1.55% | +22.91% | +13.85% | +5.51% | -2.90% | +1.62% | -3.66% | +13.01% | 12TCr | ||
| -2.02% | -1.25% | +2.05% | +2.24% | +3.75% | +5.20% | +34.20% | -2.86% | -0.60% | 10TCr | ||
| -0.32% | +3.53% | +20.44% | +18.53% | +23.39% | +37.33% | +19.57% | +48.18% | +126.72% | 9.56TCr | ||
| -3.63% | -19.97% | -1.26% | +239.97% | +629.98% | +769.08% | +181.21% | -8.11% | - | 8.71TCr | ||
| -0.54% | +2.49% | +15.88% | +6.93% | -10.95% | -13.68% | +49.70% | +76.82% | +562.26% | 7.61TCr | ||
| +0.84% | +1.10% | +4.61% | +10.70% | +23.16% | +30.45% | -3.79% | -31.11% | +59.42% | 7.16TCr | ||
| Average | -0.73% | +0.08% | +8.10% | +22.87% | +50.37% | +61.36% | +59.70% | +89.06% | +274.06% | 28TCr | |
| Weighted average by Cap. | -1.00% | +0.63% | +8.73% | +17.30% | +35.57% | +43.10% | +82.47% | +164.63% | +552.18% |
- Stock Market
- Stocks
- AZN Stock
- Sector AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
















